Skip to content

Evaluation of a Hearing Device for Transmitting Sound to the Inner Ear

Evaluation of a Sound Processor for a Transcutaneous System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05628285
Enrollment
11
Registered
2022-11-28
Start date
2022-11-15
Completion date
2024-11-15
Last updated
2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conductive Hearing Loss, Mixed Hearing Loss

Brief summary

A single center study evaluating the performance of an externally worn sound processor for a transcutaneous bone anchored hearing system using audiological outcomes measures such as aided thresholds and self-evaluation questionnaires.

Detailed description

Bone conduction hearing systems use the body's natural ability to transfer sound through bone conduction. The sound processor picks up sound and converts it into vibrations that are transferred through the skull bone to the inner ear (cochlea). Thus, for patients with conductive or mixed hearing losses, patients with lasting hearing loss following a middle ear disease or malformations (such as microtia), the vibrations are bypassing the conductive problem in the ear canal or middle ear. Bone conduction devices currently on the market are divided into three types; transcutaneous direct drive, percutaneous (skin penetrating) direct drive and transcutaneous skin drive bone conduction devices. This evaluation focus on a sound processor used for a transcutaneous system.

Interventions

DEVICESentio 1

Sound processor

Sponsors

Oticon Medical
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Signed Informed Consent Form 2. Adult subjects (18 years or older) 3. Subjects implanted with an I1 implant 4. Fluent in Swedish

Exclusion criteria

1. Subjects who do not have the ability or are un-willing to follow investigational procedures/requirements, e.g., to complete questionnaires, according to investigator's discretion. 2. Subject deemed unsuitable for any medical or other reason as judged by PI or medical responsible.

Design outcomes

Primary

MeasureTime frameDescription
To Assess the Improvement of Hearing With the Sentio1 (PTA4)1 monthFunctional gain with Sentio 1, i.e., the difference in dB between unaided and aided sound field thresholds, calculated on average for frequencies 500, 1000, 2000 and 4000 Hz (PTA4). In detail, for each patient, sound field thresholds are measured at the frequencies 500, 1000, 2000 and 4000 Hz for which a mean value is calculated and denoted as PTA4. The primary outcome measure is functional gain which is the difference in PTA4 measured unaided (without sound processor) versus aided condition (with sound processor).

Secondary

MeasureTime frameDescription
Subjective Evaluation of Sound Processor Performance.1 monthSentio 1 compared to previous sound processor. 1. Average SSQ12 scores with Sentio 1 for each question, sub-scales and in total. 2. Average SSQ12 scores with current sound processor for each question, sub-scales and in total. 3. Difference in SSQ12 scores between Sentio 1 and current sound processor for each question, sub-scales and in total. Measured by the Speech, Spatial and Quality (SSQ) scale from 0-10 where 0 represents Not at all and 10 represents Perfect. Higher scores mean a better outcome. For each of the scales the item outcomes are averaged. Fot the total score all items are averaged
Subjective Sound Processor Preference1 monthPercentage (%) of subjects who prefer the Sentio 1 over current sound processor
To Assess the Improvement of Hearing With the Sentio11 monthFunctional gain with Sentio 1, i.e., the difference in dB between unaided (without sound processor) and aided (with sound processor on) sound field thresholds, for all measured frequencies. In detail, for each patient, sound field thresholds are measured at the frequencies 250, 500, 1000, 2000, 3000, 4000, 6000 and 8000 Hz, with and without the sound processor on.
To Assess the Difference Between BC In-situ Thresholds Measured With Sentio 1 and Conventional Unmasked BC Audiometry.1 monthDifference in dB between Sentio 1 BC in situ thresholds and BC thresholds measured with conventional unmasked BC audiometry for the frequencies 500, 1000, 2000, 3000 and 4000 Hz. The BC in-situ threshold is a measure of the inner ear functionality with the device. This should correspond to the unmasked BC thresholds measured with conventional audiometry. The difference was calculated as the threshold value measured with Sentio 1 minus the threshold value measured with conventional audiometry. Negative values indicate that the thresholds measured with Sentio 1 were lower (better) compared to those measured with conventional audiometry. Conversely, positive values indicate that the thresholds measured with Sentio 1 were higher (worse) compared to conventional audiometry. It's expected that two measurements should be comparable to each with a difference of maximum +/-5 dB.
Assess Safety With the Sentio 1 Sound Processor12 monthsTabulation of AEs occurred throughout the investigation and percentage of individuals with reported AEs.
To Assess the Degree to Which Sentio 1 Compensates for the BC Hearing Loss1 month1. Effective gain defined as the difference in dB between aided sound field thresholds with Sentio 1 and unmasked BC thresholds on the aided ear(s). The effective gain is calculated for all measured frequencies. 2. Effective gain with Sentio 1, see definition above, calculated in average for frequencies 500, 1000, 2000 and 4000 Hz (PTA4).

Countries

Sweden

Participant flow

Participants by arm

ArmCount
Sentio 1 Sound Processor
The sound processor picks up the sound and transfer it to the implant that convert the sound to vibrations that are transmitted to the inner ear. Sentio 1: Sound processor
11
Total11

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up1

Baseline characteristics

CharacteristicSentio 1 Sound Processor
Age, Continuous51 years
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 11
other
Total, other adverse events
0 / 11
serious
Total, serious adverse events
0 / 11

Outcome results

Primary

To Assess the Improvement of Hearing With the Sentio1 (PTA4)

Functional gain with Sentio 1, i.e., the difference in dB between unaided and aided sound field thresholds, calculated on average for frequencies 500, 1000, 2000 and 4000 Hz (PTA4). In detail, for each patient, sound field thresholds are measured at the frequencies 500, 1000, 2000 and 4000 Hz for which a mean value is calculated and denoted as PTA4. The primary outcome measure is functional gain which is the difference in PTA4 measured unaided (without sound processor) versus aided condition (with sound processor).

Time frame: 1 month

ArmMeasureValue (MEAN)Dispersion
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Improvement of Hearing With the Sentio1 (PTA4)32.5 dBStandard Deviation 6.8
Secondary

Assess Safety With the Sentio 1 Sound Processor

Tabulation of AEs occurred throughout the investigation and percentage of individuals with reported AEs.

Time frame: 12 months

Secondary

Subjective Evaluation of Sound Processor Performance.

Sentio 1 compared to previous sound processor. 1. Average SSQ12 scores with Sentio 1 for each question, sub-scales and in total. 2. Average SSQ12 scores with current sound processor for each question, sub-scales and in total. 3. Difference in SSQ12 scores between Sentio 1 and current sound processor for each question, sub-scales and in total. Measured by the Speech, Spatial and Quality (SSQ) scale from 0-10 where 0 represents Not at all and 10 represents Perfect. Higher scores mean a better outcome. For each of the scales the item outcomes are averaged. Fot the total score all items are averaged

Time frame: 1 month

ArmMeasureGroupValue (MEAN)Dispersion
Functional Gain PTA4 (Sentio 1 Sound Processor)Subjective Evaluation of Sound Processor Performance.SSQ Speech5.58 score on a scaleStandard Deviation 2.32
Functional Gain PTA4 (Sentio 1 Sound Processor)Subjective Evaluation of Sound Processor Performance.SSQ Spatial4.34 score on a scaleStandard Deviation 3.02
Functional Gain PTA4 (Sentio 1 Sound Processor)Subjective Evaluation of Sound Processor Performance.SSQ Quality6.21 score on a scaleStandard Deviation 2.12
Functional Gain PTA4 (Sentio 1 Sound Processor)Subjective Evaluation of Sound Processor Performance.SSQ Total5.47 score on a scaleStandard Deviation 2.18
Sentio 1 Sound ProcessorSubjective Evaluation of Sound Processor Performance.SSQ Total5.78 score on a scaleStandard Deviation 2.26
Sentio 1 Sound ProcessorSubjective Evaluation of Sound Processor Performance.SSQ Speech6.07 score on a scaleStandard Deviation 2.67
Sentio 1 Sound ProcessorSubjective Evaluation of Sound Processor Performance.SSQ Quality6.22 score on a scaleStandard Deviation 1.7
Sentio 1 Sound ProcessorSubjective Evaluation of Sound Processor Performance.SSQ Spatial4.68 score on a scaleStandard Deviation 2.9
Difference Between Visit 2 (Sentio 1) and Visit 1 (Previous Device)Subjective Evaluation of Sound Processor Performance.SSQ Total0.402 score on a scaleStandard Deviation 0.937
Difference Between Visit 2 (Sentio 1) and Visit 1 (Previous Device)Subjective Evaluation of Sound Processor Performance.SSQ Spatial0.353 score on a scaleStandard Deviation 1.59
Difference Between Visit 2 (Sentio 1) and Visit 1 (Previous Device)Subjective Evaluation of Sound Processor Performance.SSQ Quality0.154 score on a scaleStandard Deviation 0.92
Difference Between Visit 2 (Sentio 1) and Visit 1 (Previous Device)Subjective Evaluation of Sound Processor Performance.SSQ Speech0.579 score on a scaleStandard Deviation 1.537
Secondary

Subjective Sound Processor Preference

Percentage (%) of subjects who prefer the Sentio 1 over current sound processor

Time frame: 1 month

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Functional Gain PTA4 (Sentio 1 Sound Processor)Subjective Sound Processor Preference7 Participants
Secondary

To Assess the Degree to Which Sentio 1 Compensates for the BC Hearing Loss

1. Effective gain defined as the difference in dB between aided sound field thresholds with Sentio 1 and unmasked BC thresholds on the aided ear(s). The effective gain is calculated for all measured frequencies. 2. Effective gain with Sentio 1, see definition above, calculated in average for frequencies 500, 1000, 2000 and 4000 Hz (PTA4).

Time frame: 1 month

ArmMeasureGroupValue (MEAN)Dispersion
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Degree to Which Sentio 1 Compensates for the BC Hearing Loss500Hz20.5 dBStandard Deviation 13.6
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Degree to Which Sentio 1 Compensates for the BC Hearing Loss1000Hz11.0 dBStandard Deviation 7.4
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Degree to Which Sentio 1 Compensates for the BC Hearing Loss2000Hz1.50 dBStandard Deviation 10.01
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Degree to Which Sentio 1 Compensates for the BC Hearing Loss3000Hz12.5 dBStandard Deviation 9.2
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Degree to Which Sentio 1 Compensates for the BC Hearing Loss4000Hz14.5 dBStandard Deviation 9
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Degree to Which Sentio 1 Compensates for the BC Hearing LossPTA411.9 dBStandard Deviation 7.7
Secondary

To Assess the Difference Between BC In-situ Thresholds Measured With Sentio 1 and Conventional Unmasked BC Audiometry.

Difference in dB between Sentio 1 BC in situ thresholds and BC thresholds measured with conventional unmasked BC audiometry for the frequencies 500, 1000, 2000, 3000 and 4000 Hz. The BC in-situ threshold is a measure of the inner ear functionality with the device. This should correspond to the unmasked BC thresholds measured with conventional audiometry. The difference was calculated as the threshold value measured with Sentio 1 minus the threshold value measured with conventional audiometry. Negative values indicate that the thresholds measured with Sentio 1 were lower (better) compared to those measured with conventional audiometry. Conversely, positive values indicate that the thresholds measured with Sentio 1 were higher (worse) compared to conventional audiometry. It's expected that two measurements should be comparable to each with a difference of maximum +/-5 dB.

Time frame: 1 month

ArmMeasureGroupValue (MEAN)Dispersion
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Difference Between BC In-situ Thresholds Measured With Sentio 1 and Conventional Unmasked BC Audiometry.500Hz-4.7 dBStandard Error 11.5
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Difference Between BC In-situ Thresholds Measured With Sentio 1 and Conventional Unmasked BC Audiometry.1000Hz-3.4 dBStandard Error 9
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Difference Between BC In-situ Thresholds Measured With Sentio 1 and Conventional Unmasked BC Audiometry.2000Hz-6.7 dBStandard Error 7.9
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Difference Between BC In-situ Thresholds Measured With Sentio 1 and Conventional Unmasked BC Audiometry.3000Hz8.2 dBStandard Error 8.4
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Difference Between BC In-situ Thresholds Measured With Sentio 1 and Conventional Unmasked BC Audiometry.4000Hz9.9 dBStandard Error 9.2
Secondary

To Assess the Improvement of Hearing With the Sentio1

Functional gain with Sentio 1, i.e., the difference in dB between unaided (without sound processor) and aided (with sound processor on) sound field thresholds, for all measured frequencies. In detail, for each patient, sound field thresholds are measured at the frequencies 250, 500, 1000, 2000, 3000, 4000, 6000 and 8000 Hz, with and without the sound processor on.

Time frame: 1 month

ArmMeasureGroupValue (MEAN)Dispersion
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Improvement of Hearing With the Sentio1250Hz18.5 dBStandard Deviation 11.6
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Improvement of Hearing With the Sentio1500Hz29.5 dBStandard Deviation 12.1
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Improvement of Hearing With the Sentio11000Hz35.0 dBStandard Deviation 6.2
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Improvement of Hearing With the Sentio12000Hz33.5 dBStandard Deviation 10.3
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Improvement of Hearing With the Sentio13000Hz35.0 dBStandard Deviation 13.1
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Improvement of Hearing With the Sentio14000Hz32.0 dBStandard Deviation 8.9
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Improvement of Hearing With the Sentio16000Hz23.5 dBStandard Deviation 9.1
Functional Gain PTA4 (Sentio 1 Sound Processor)To Assess the Improvement of Hearing With the Sentio18000Hz17.8 dBStandard Deviation 12.9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026